GLP-1R agonists are a class of drugs targeting the incretin system that are now being investigated as potential medications to treat GDM, due to numerous recent publications showing their beneficial effects on insulin sensitivity and glucose intolerance during pregnancy [57–59]. Here, GLP1R is linked to Glucose intolerance.